Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Organon & Co. Common Stock (NY:OGN)

8.840 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Apr 21, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	4,540
Open	8.840
Bid (Size)	9.010 (500)
Ask (Size)	9.280 (300)
Prev. Close	8.840
Today's Range	8.840 - 8.840
52wk Range	5.690 - 13.24
Shares Outstanding	259,965,579
Dividend Yield	0.90%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis

April 15, 2026

From Organon & Co.

Via Business Wire

3 Reasons to Avoid OGN and 1 Stock to Buy Instead

April 13, 2026

Over the last six months, Organon’s shares have sunk to $9.03, producing a disappointing 5.9% loss - a stark contrast to the S&P 500’s 2.5% gain. This may ha...

Via StockStory

Performance

YTD	+22.1%	+22.1%
1 Month	+45.2%	+45.2%
3 Month	-6.6%	-6.6%
6 Month	-2.0%	-2.0%
1 Year	-16.8%	-16.8%

More News

Traders are paying attention to the gapping stocks in Friday's session. ↗

April 10, 2026

Via Chartmill

Organon & Co (NYSE:OGN) Shares Drop on Q4 Earnings Miss and Flat 2026 Outlook ↗

February 12, 2026

Via Chartmill

Discover the top movers in Friday's pre-market session. ↗

April 10, 2026

Via Chartmill

Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know

April 06, 2026

Via StockStory

Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age

March 27, 2026

From Organon & Co.

Via Business Wire

3 Cash-Producing Stocks We’re Skeptical Of

March 23, 2026

Via StockStory

Does This $25 Million Bet on a Stock Down 61% Signal Turnaround Potential at $6? ↗

March 20, 2026

Via The Motley Fool

3 Value Stocks We Approach with Caution

March 20, 2026

Via StockStory

1 Stock Under $10 to Own for Decades and 2 That Underwhelm

March 19, 2026

Via StockStory

3 of Wall Street’s Favorite Stocks We Approach with Caution

March 13, 2026

Via StockStory

3 Small-Cap Stocks We Approach with Caution

March 04, 2026

Via StockStory

New Analysis of Organon’s VTAMA® (tapinarof) cream, 1%, Phase 3 Data Showed Early and Consistent Improvement in Patient-Reported Sleep Subdomains in Pediatric Patients Down to 2 Years of Age with Atopic Dermatitis

February 27, 2026

From Organon & Co.

Via Business Wire

The Pivot to Growth: Viatris (VTRS) Enters Phase 2 with 2026 Dividend and Capital Allocation Strategy

February 26, 2026

Via Finterra

Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device

February 23, 2026

From Organon & Co.

Via Business Wire

5 Revealing Analyst Questions From Organon’s Q4 Earnings Call

February 19, 2026

Via StockStory

Amphastar Pharmaceuticals, Novavax, and Organon Shares Skyrocket, What You Need To Know

February 13, 2026

Via StockStory

OGN Q4 Deep Dive: Margin Compression and U.S. Headwinds Shape 2026 Outlook

February 13, 2026

Via StockStory

Organon (OGN) Q4 2025 Earnings Call Transcript ↗

February 12, 2026

Via The Motley Fool

Organon (NYSE:OGN) Reports Q4 CY2025 In Line With Expectations

February 12, 2026

Via StockStory

Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025

February 12, 2026

From Organon & Co.

Via Business Wire

Organon Earnings: What To Look For From OGN

February 10, 2026

Via StockStory

2 Healthcare Stocks with Promising Prospects and 1 We Brush Off

February 04, 2026

Via StockStory

Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026

January 29, 2026

From Organon & Co.

Via Business Wire

Frequently Asked Questions

Is Organon & Co. Common Stock publicly traded?

Yes, Organon & Co. Common Stock is publicly traded.

What exchange does Organon & Co. Common Stock trade on?

Organon & Co. Common Stock trades on the New York Stock Exchange

What is the ticker symbol for Organon & Co. Common Stock?

The ticker symbol for Organon & Co. Common Stock is OGN on the New York Stock Exchange

What is the current price of Organon & Co. Common Stock?

The current price of Organon & Co. Common Stock is 8.840

When was Organon & Co. Common Stock last traded?

The last trade of Organon & Co. Common Stock was at 04/21/26 07:00 PM ET

What is the market capitalization of Organon & Co. Common Stock?

The market capitalization of Organon & Co. Common Stock is 2.30B

How many shares of Organon & Co. Common Stock are outstanding?

Organon & Co. Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.